Phosphodiesterase 5 inhibition restores impaired ACh relaxation in hypertensive conduit pulmonary arteries

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Oka, Masahiko ^a,b  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic hypoxia; Endothelium dependent relaxation; Guanosine 3 ,5 cyclic monophosphate; Sodium nitroprusside

Indexed keywords

1 [6 CHLORO 4 (3,4 METHYLENEDIOXYBENZYLAMINO) 2 QUINAZOLINYL] 4 PIPERIDINECARBOXYLIC ACID; ACETYLCHOLINE; CYCLIC GMP; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); DRUG EFFECT; ENZYME INHIBITION; HYPOXIA; LUNG ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; VASODILATATION;

EID: 0035017894     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l432     Document Type: Article

References (20)

1. Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigaut R, and Fratacci M-D. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 148: 310-316, 1993.
2. A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol 22: 39-43, 1993.
3. Dinh-Xuan AT, Higenbottam TM, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, and Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obsstructive lung disease. N Engl J Med 324: 1539-1547, 1991.
4. Dinerman JL, Lowenstein CJ, and Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res 73: 217-222, 1993.
5. Isaacson TC, Hampl V, Weir EK, Nelson DP, and Archer SL. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol 76: 933-940, 1994.
6. Kodama K, Adachi H, Mori H, and Saito N. Effects of novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs. Eur J Pharmacol 263: 93-99, 1994.
7. Le Cras TD, Xue C, Rengasamy A, and Johns RA. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am J Physiol Lung Cell Mol Physiol 270: L164-L170, 1996.
8. Li D, Zhou N, and Johns RA. Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia. Am J Physiol Lung Cell Mol Physiol 277: L841-L847, 1999.
9. MacLean MR, Johnston ED, McCulloch KM, Pooley L, and Sweeney G. Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283: 619-624, 1997.
10. Maruyama J and Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am J Physiol Heart Circ Physiol 266: H2476-H2488, 1994.
11. Muramatsu M, Tyler RC, Rodman DM, and McMurtry IF. Thapsigargin stimulates increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries. J Appl Physiol 80: 1336-1344, 1996.
12. Ohnishi M, Oka M, Muramatsu M, Sato K, Kira S, and Fukuchi Y. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs. J Cardiovasc Pharmacol 33: 619-624, 1999.
13. Oka M, Hasunuma K, Webb SA, Stelzner TJ, Rodman DM, and McMurtry IF. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol Lung Cell Mol Physiol 264: L587-L597, 1993.
14. Orton EC, Reeves JT, and Stenmark KR. Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension. J Appl Physiol 65: 2459-2467, 1988.
15. Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, and Magnussen H. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol Lung Cell Mol Physiol 266: L536-L543, 1994.
16. Resta TC and Walker BR. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am J Physiol Heart Circ Physiol 270: H888-H896, 1996.
17. + channel-mediated relaxation. Am J Physiol Lung Cell Mol Physiol 263: L88-L94, 1992.
18. Saeki T, Adachi H, Takase Y, Yoshitake S, Souda S, and Saito I. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery. J Pharmacol Exp Ther 272: 825-831, 1995.
19. Wanstall JC and O'Donnell SR. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br J Pharmacol 105: 152-158, 1992.
20. Xue C, Rengasamy A, LeCras TD, Koberna PA, Dailey GC, and Johns RA. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 267: L667-L678, 1994.